MOTS-c + Tirzepatide

Ask about this stack

Get a grounded answer across clinical evidence, community patterns, and risks.

Ask AI →

26

authors mention this stack

18

ran the components concurrently

MOTS-c + Tirzepatide (MOTS-c + Tirzepatide) appears in 26 author journeys (18 as actual concurrent use). Common goals: Tirzepatide for weight loss and managing early menopause; MOTS-C to treat chronic fatigue.; General discussion on how to stack MOTS-C while on Tirzepatide; To combat the standard exhaustion/fatigue experienced on Tirzepatide shot days and to boost workout performance.. Typical doses reported: MOTS-c 5mg, Tirzepatide 5mg. Reported side effects include: MOTS-C caused localized injection site redness, swelling, and burning/stinging that lasted for about 4 hours. Tirzepatide caused sulfur burps and gas when she briefly increased the dose to 5mg. Research: the components appear across 565 studies, but direct combination trials are limited.

Research support

Direct combination trials are limited. Per-component literature:

MOTS-c 84 studies (7 clinical)
Tirzepatide 481 studies (248 clinical)

PubMed/PMC articles mentioning each compound in title or abstract.

Typical doses reported

Community-reported doses are not medical guidance.

How people are running it

12

Currently running

6

Ran in the past

6

Planning to run

2

Recommended / discussed

What people use it for

Tirzepatide for weight loss and managing early menopause; MOTS-C to treat chronic fatigue.General discussion on how to stack MOTS-C while on TirzepatideTo combat the standard exhaustion/fatigue experienced on Tirzepatide shot days and to boost workout performance.weight loss and health optimizationfatigueWeight loss and managing Tirzepatide-induced fatigue

Sample reported outcomes

  • Tirzepatide successfully suppressed food noise and reduced hot flashes. MOTS-C initially provided energy (speed-cleaning) but subsequently caused severe mid-day energy crashes/extreme fatigue.
  • Excellent synergy. Provided clean, non-jittery energy, improved gym/cardio output, and successfully mitigated Tirzepatide-induced fatigue.
  • Beer did not taste the same, stopped drinking
  • Maintained energy levels with no decrease in energy after stopping SS-31
  • MOTS-c gives massive energy after 3 weeks
  • Significant improvement in energy levels, alertness throughout the day, and improved stamina during exercise/hiking.
  • Lost 15 pounds in the first 4 weeks, currently experiencing a weight stall
  • Loved the cycle; experienced increased energy, better weightlifting sessions, and reduced Tirzepatide-induced fatigue

Self-reported community experiences, not verified results.

Sample reported side effects

  • MOTS-C caused localized injection site redness, swelling, and burning/stinging that lasted for about 4 hours. Tirzepatide caused sulfur burps and gas when she briefly increased the dose to 5mg.
  • Injection site reaction (ISR) burn/sting
  • Injection site lumps from MOTS-c that took a week to resolve.
  • Severe headache after drinking a higher ABV beer
  • Fatigue from Tirzepatide
  • Mild injection site reactions from MOTS-C (minor redness and very mild stinging/burning).
  • Appetite suppression, mild nausea only when forcing self to eat
  • Subcutaneous injection stings/burns for about an hour; experienced increased sweating and feeling warmer on days taking MOTS-c